Research Article

The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Nonfasting Remnant Cholesterol in a Real World Population

Figure 1

Change in remnant cholesterol levels from pretreatment to posttreatment by pretreatment triglyceride groups (error bars: 95% CI).
(a)
(b)
(c)